<DOC>
	<DOC>NCT00791323</DOC>
	<brief_summary>A pilot study to evaluate the extent of PGE2 inhibition (mean aqueous values) by Ketorolac 0.04% following peripheral iridotomy</brief_summary>
	<brief_title>Efficacy of Ketorolac 0.4% in Prostaglandin Suppression</brief_title>
	<detailed_description />
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Ketorolac</mesh_term>
	<mesh_term>Ketorolac Tromethamine</mesh_term>
	<mesh_term>Lubricant Eye Drops</mesh_term>
	<criteria>Patients scheduled to undergo phakic IOL implantation History of intraocular surgery in the operative eye</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2011</verification_date>
</DOC>